• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 MALDI 的用于评估肾损伤标志物的方法的进一步研究。

A further investigation on a MALDI-based method for evaluation of markers of renal damage.

机构信息

Department of Medical and Surgical Sciences, Padova University, Via Giustiniani 2, I35100 Padova, Italy.

出版信息

J Mass Spectrom. 2009 Dec;44(12):1754-60. doi: 10.1002/jms.1685.

DOI:10.1002/jms.1685
PMID:19852035
Abstract

The validity of the urinary protein profile to characterize the pathological states of diabetic, nephropathic and diabetic-nephropathic patients was considered on the basis of previously obtained results by MALDI/MS, showing a different abundance ratio of the collagen alpha1 and alpha5 chain precursor fragments at m/z 1219 and 2049 and of the uromodulin precursor fragment at m/z 1912 observed in healthy subjects and patients; a larger number of subjects was examined and the obtained results were statistically evaluated. The p values related to the observed differences indicate that they are statistically significant when comparing all patients versus healthy controls, diabetic with normo or microalbuminuria versus nephropathic with advanced renal disease patients and diabetic with normo or microalbuminuria versus diabetic with advanced nephropathy patients. The scatter plot matrix gives evidence of the strict inverse relationship between the abundances of ions at m/z 1912 and 1219, the correlation coefficient being particularly high (r = 0.921, p < 0.001). The relationship between the true positive rate (sensitivity) and false positive rate (1-specificity) for every possible cutoff value in abundance of the considered ionic species was investigated through the receiver-operating characteristic (ROC) curve. The obtained data indicate that a good differentiation of nephropathic patients with advanced renal disease and diabetic patients with advanced nephropathy versus healthy subjects can be easily obtained by this approach.

摘要

基于 MALDI/MS 先前获得的结果,考虑了尿蛋白谱在糖尿病肾病和糖尿病肾病患者病理状态特征化中的有效性,结果显示健康受试者和患者中存在不同的胶原 alpha1 和 alpha5 链前体片段以及尿调素前体片段的丰度比值,在 m/z 1219 和 2049 处观察到,在 m/z 1912 处观察到;检查了更多的受试者,并对获得的结果进行了统计学评估。与观察到的差异相关的 p 值表明,当将所有患者与健康对照、糖尿病伴正常或微量白蛋白尿与肾病伴晚期肾病患者以及糖尿病伴正常或微量白蛋白尿与糖尿病伴晚期肾病患者进行比较时,这些差异具有统计学意义。散点图矩阵证明了 m/z 1912 和 1219 处离子丰度之间的严格反比关系,相关系数特别高(r = 0.921,p < 0.001)。通过接收者操作特征 (ROC) 曲线研究了考虑离子物种丰度的每个可能截止值的真阳性率(灵敏度)和假阳性率(1 特异性)之间的关系。获得的数据表明,通过这种方法可以很容易地对晚期肾病患者和晚期肾病患者与健康受试者进行区分。

相似文献

1
A further investigation on a MALDI-based method for evaluation of markers of renal damage.基于 MALDI 的用于评估肾损伤标志物的方法的进一步研究。
J Mass Spectrom. 2009 Dec;44(12):1754-60. doi: 10.1002/jms.1685.
2
Low molecular weight proteins in urines from healthy subjects as well as diabetic, nephropathic and diabetic-nephropathic patients: a MALDI study.健康受试者以及糖尿病患者、肾病患者和糖尿病肾病患者尿液中的低分子量蛋白质:一项基质辅助激光解吸电离研究
J Mass Spectrom. 2009 Mar;44(3):419-25. doi: 10.1002/jms.1520.
3
Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.鉴定尿可溶性E-钙黏蛋白作为糖尿病肾病的一种新型生物标志物。
Diabetes Metab Res Rev. 2009 Mar;25(3):232-41. doi: 10.1002/dmrr.940.
4
Urinary peptides as a diagnostic tool for renal failure detected by matrix-assisted laser desorption/ionisation mass spectrometry: an evaluation of their clinical significance.通过基质辅助激光解吸/电离质谱法检测尿肽作为肾衰竭诊断工具:对其临床意义的评估
Eur J Mass Spectrom (Chichester). 2011;17(3):245-53. doi: 10.1255/ejms.1124.
5
The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.糖尿病肾病中晚期糖基化终产物血清水平的意义。
Metabolism. 2000 Aug;49(8):1030-5. doi: 10.1053/meta.2000.7738.
6
Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.2型糖尿病患者尿液中转化生长因子β诱导基因h3(βig-h3)的浓度
Diabet Med. 2005 Jan;22(1):14-20. doi: 10.1111/j.1464-5491.2004.01295.x.
7
Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder.用于准确预测糖尿病肾病的尿蛋白标志物的蛋白质组学分析
J Assoc Physicians India. 2005 Jun;53:513-20.
8
Serum and urinary type IV collagen concentrations in the assessment of diabetic microangiopathy.血清和尿Ⅳ型胶原浓度在糖尿病微血管病变评估中的应用
Hiroshima J Med Sci. 1994 Dec;43(4):123-33.
9
Proteomic identification of urinary biomarkers of diabetic nephropathy.糖尿病肾病尿液生物标志物的蛋白质组学鉴定
Diabetes Care. 2007 Mar;30(3):629-37. doi: 10.2337/dc06-2056.
10
Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.2型糖尿病肾病患者尿βig-h3(转化生长因子-β诱导蛋白)水平升高。
Diabetes Res Clin Pract. 2004 Aug;65(2):167-73. doi: 10.1016/j.diabres.2004.01.007.

引用本文的文献

1
Proteomic biomarkers in kidney disease: issues in development and implementation.肾脏疾病的蛋白质组学生物标志物:研发和应用中的问题。
Nat Rev Nephrol. 2015 Apr;11(4):221-32. doi: 10.1038/nrneph.2014.247. Epub 2015 Feb 3.
2
Urinary peptide profiling to differentiate between minimal change disease and focal segmental glomerulosclerosis.尿液肽谱分析用于鉴别微小病变性肾病和局灶节段性肾小球硬化症。
PLoS One. 2014 Jan 30;9(1):e87731. doi: 10.1371/journal.pone.0087731. eCollection 2014.
3
Mass spectrometry for diabetic nephropathy monitoring: new effective tools for physicians.
用于糖尿病肾病监测的质谱分析:为医生提供的新型有效工具。
ISRN Endocrinol. 2012;2012:768159. doi: 10.5402/2012/768159. Epub 2012 May 20.